Literature DB >> 21212457

An emerging 1q21.1 deletion-associated neurodevelopmental phenotype.

Lina Basel-Vanagaite1, Hadassa Goldberg-Stern, Aviva Mimouni-Bloch, Vered Shkalim, Detlef Böhm, Jürgen Kohlhase.   

Abstract

In this study, we describe the neurodevelopmental and epileptic phenotypes in a family with an inherited 1q21.1 deletion. During the pregnancy with the proband, increased nuchal translucency and oligohydramnion were detected. The proband showed mild global developmental delay and ataxic gait. Seizures started in the proband at the age of 2 years and manifested as generalized tonic-clonic seizures, atypical absence seizures, head drops, and drop attacks with no abnormal findings on interictal electroencephalogram. We performed an Agilent Human Genome CGH (comparative genomic hybridization) Microarray 105A, and a microdeletion on chromosome 1q21.1 was identified in both the patient and his asymptomatic father. This deletion encompasses 1.65 Mb and is larger than the reported recurrent class I deletions in this region. Cryptic cytogenetic abnormalities should be considered in patients with neurodevelopmental problems and atypical presentation of epilepsy with a normal electroencephalography (EEG).

Entities:  

Mesh:

Year:  2011        PMID: 21212457     DOI: 10.1177/0883073810377658

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  7 in total

1.  An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification.

Authors:  Owen W Stephens; Qing Zhang; Pingping Qu; Yiming Zhou; Shweta Chavan; Erming Tian; David R Williams; Joshua Epstein; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

2.  Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes.

Authors:  Jill A Rosenfeld; Ryan N Traylor; G Bradley Schaefer; Elizabeth W McPherson; Blake C Ballif; Eva Klopocki; Stefan Mundlos; Lisa G Shaffer; Arthur S Aylsworth
Journal:  Eur J Hum Genet       Date:  2012-02-08       Impact factor: 4.246

3.  Interstitial 1q21.1 Microdeletion Is Associated with Severe Skeletal Anomalies, Dysmorphic Face and Moderate Intellectual Disability.

Authors:  Bruno F Gamba; Roseli M Zechi-Ceide; Nancy M Kokitsu-Nakata; Siulan Vendramini-Pittoli; Carla Rosenberg; Ana C V Krepischi Santos; Lucilene Ribeiro-Bicudo; Antonio Richieri-Costa
Journal:  Mol Syndromol       Date:  2016-10-26

4.  Copy number variation plays an important role in clinical epilepsy.

Authors:  Heather Olson; Yiping Shen; Jennifer Avallone; Beth R Sheidley; Rebecca Pinsky; Ann M Bergin; Gerard T Berry; Frank H Duffy; Yaman Eksioglu; David J Harris; Fuki M Hisama; Eugenia Ho; Mira Irons; Christina M Jacobsen; Philip James; Sanjeev Kothare; Omar Khwaja; Jonathan Lipton; Tobias Loddenkemper; Jennifer Markowitz; Kiran Maski; J Thomas Megerian; Edward Neilan; Peter C Raffalli; Michael Robbins; Amy Roberts; Eugene Roe; Caitlin Rollins; Mustafa Sahin; Dean Sarco; Alison Schonwald; Sharon E Smith; Janet Soul; Joan M Stoler; Masanori Takeoka; Wen-Han Tan; Alcy R Torres; Peter Tsai; David K Urion; Laura Weissman; Robert Wolff; Bai-Lin Wu; David T Miller; Annapurna Poduri
Journal:  Ann Neurol       Date:  2014-06-13       Impact factor: 10.422

5.  Clinical phenotype of the recurrent 1q21.1 copy-number variant.

Authors:  Raphael Bernier; Kyle J Steinman; Beau Reilly; Arianne Stevens Wallace; Elliott H Sherr; Nicholas Pojman; Heather C Mefford; Jennifer Gerdts; Rachel Earl; Ellen Hanson; Robin P Goin-Kochel; Leandra Berry; Stephen Kanne; LeeAnne Green Snyder; Sarah Spence; Melissa B Ramocki; David W Evans; John E Spiro; Christa L Martin; David H Ledbetter; Wendy K Chung
Journal:  Genet Med       Date:  2015-06-11       Impact factor: 8.822

6.  Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era.

Authors:  Gregory Costain; Anne S Bassett
Journal:  Appl Clin Genet       Date:  2012-02-20

Review 7.  Dissecting Molecular Genetic Mechanisms of 1q21.1 CNV in Neuropsychiatric Disorders.

Authors:  Joy Yoon; Yingwei Mao
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.